{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T08:04:13Z","timestamp":1784966653062,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.urolonc.2020.07.016","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T09:48:52Z","timestamp":1597052932000},"page":"132.e1-132.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of noninvasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy on bladder-sparing strategy in patients with muscle-invasive bladder cancer"],"prefix":"10.1016","volume":"39","author":[{"given":"Takehisa","family":"Onishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Sekito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Shibahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Yabana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.urolonc.2020.07.016_bib0001","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","article-title":"Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer","volume":"71","author":"Alfred Witjes","year":"2017","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2020.07.016_bib0002","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.eururo.2014.11.043","article-title":"Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial","volume":"67","author":"Bochner","year":"2015","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2020.07.016_bib0003","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.eururo.2013.01.010","article-title":"Complications after robot-assisted radical cystectomy: results from the international robotic cystectomy consortium","volume":"64","author":"Johar","year":"2013","journal-title":"Eur Urol"},{"issue":"2-3","key":"10.1016\/j.urolonc.2020.07.016_bib0004","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.euf.2016.04.008","article-title":"Underutilization of radical cystectomy among patients diagnosed with clinical stage T2 muscle-invasive bladder cancer","volume":"3","author":"Williams","year":"2017","journal-title":"Eur Urol Focus"},{"issue":"1","key":"10.1016\/j.urolonc.2020.07.016_bib0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.eururo.2014.02.038","article-title":"Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review","volume":"66","author":"Ploussard","year":"2014","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.urolonc.2020.07.016_bib0006","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.urolonc.2020.07.016_bib0007","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.eururo.2007.12.031","article-title":"Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer","volume":"54","author":"Herr","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.07.016_bib0008","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.urology.2017.09.003","article-title":"Outcomes following clinical complete response to neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder in patients refusing radical cystectomy","volume":"111","author":"Robins","year":"2018","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.urolonc.2020.07.016_bib0009","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.juro.2018.05.078","article-title":"Conservative management following complete clinical response to neoadjuvant chemotherapy of muscle invasive bladder cancer: contemporary outcomes of a multi-institutional cohort study","volume":"200","author":"Mazza","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.07.016_bib0010","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.urolonc.2020.07.016_bib0011","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.eururo.2013.06.049","article-title":"Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis","volume":"65","author":"Petrelli","year":"2014","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2020.07.016_bib0012","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.juro.2015.10.133","article-title":"Final pathological stage after neoadjuvant chemotherapy and radical cystectomy for bladder cancer-does pT0 predict better survival than pTa\/Tis\/T1?","volume":"195","author":"Zargar","year":"2016","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2020.07.016_bib0013","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.euf.2016.12.005","article-title":"Absence of tumor on repeat transurethral resection of bladder tumor does not predict final pathologic T0 stage in bladder cancer treated with radical cystectomy","volume":"4","author":"Kukreja","year":"2018","journal-title":"Eur Urol Focus"},{"issue":"5","key":"10.1016\/j.urolonc.2020.07.016_bib0014","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1464-410X.2007.07132.x","article-title":"A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome","volume":"100","author":"Nielsen","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.07.016_bib0015","doi-asserted-by":"crossref","first-page":"166.e1","DOI":"10.1016\/j.urolonc.2015.11.006","article-title":"The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: a Netherlands Cancer Registry analysis","volume":"34","author":"Bruins","year":"2016","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2020.07.016_bib0016","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.euo.2018.09.004","article-title":"Delaying radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer is associated with adverse survival outcomes","volume":"2","author":"Boeri","year":"2019","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2020.07.016_bib0017","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.clgc.2014.01.005","article-title":"Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancer","volume":"12","author":"James","year":"2014","journal-title":"Clin Genitourin Cancer"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920303379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920303379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:19:05Z","timestamp":1761041945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920303379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1078143920303379"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.07.016","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of noninvasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy on bladder-sparing strategy in patients with muscle-invasive bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}